BPC-157 showed no delay in effectiveness
2007, PMID 17703734) tested AHK-Cu on isolated human hair follicles and dermal papilla cells in culture at picomolar-to-nanomolar concentrations not as a topical product on people
The peptide demonstrates the unique ability to modulate pineal gland function, restoring the natural circadian production of melatonin that declines with age
Treatment recommendations vary based on individual needs
Animal care was in compliance with standard operating procedures (SOPs) of the Pharmacology animal facility, and the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS 123)
After two days of testimony, scientific review, and debate, the Pharmacy Compounding Advisory Committee voted in favor of recommending six peptide-related bulk drug substances for inclusion on the federal 503A Bulks List